Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Friedlander

Showing results (581-590 of 636) with videos related to

Pageof 64
Sort By:
Gynecologic Oncology|May 27, 2020
The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patientsM Gleeson, M Kentwell, B Meiser, et al.
The Journal of Infectious Diseases|July 23, 2020
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With CiprofloxacinNicholas J Vietri, Steven A Tobery, Donald J Chabot, et al.
British Journal of Cancer|September 15, 2011
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancerC K Lee, R J Simes, C Brown, et al.
Scientific Reports|December 21, 2017
Connecting Neuronal Cell Protective Pathways and Drug Combinations in a Huntington's Disease Model through the Application of Quantitative Systems PharmacologyFen Pei, Hongchun Li, Mark J Henderson, et al.
ESMO Open|February 20, 2021
Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trialJ A Ledermann, A C Embleton-Thirsk, T J Perren, et al.
Genes, Chromosomes & Cancer|February 1, 1997
Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlationsG Chenevix-Trench, J Kerr, T Hurst, et al.
Nature Medicine|February 22, 2023
Epidural stimulation of the cervical spinal cord for post-stroke upper-limb paresisMarc P Powell, Nikhil Verma, Erynn Sorensen, et al.
JAMA|June 21, 2001
Tularemia as a biological weapon: medical and public health managementD T Dennis, T V Inglesby, D A Henderson, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2005
The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infectionYusheng Xiong, Judyann Wiltsie, Andrea Woods, et al.
Global Change Biology|April 15, 2025
Multi-Species Telemetry Quantifies Current and Future Efficacy of a Remote Marine Protected AreaMorgan E Gilmour, Kydd Pollock, Josh Adams, et al.
Pageof 64

Showing results (581-590 of 636) with videos related to

Sort By:
Pageof 64
Gynecologic Oncology|May 27, 2020
The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patientsM Gleeson, M Kentwell, B Meiser, et al.
The Journal of Infectious Diseases|July 23, 2020
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With CiprofloxacinNicholas J Vietri, Steven A Tobery, Donald J Chabot, et al.
British Journal of Cancer|September 15, 2011
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancerC K Lee, R J Simes, C Brown, et al.
Scientific Reports|December 21, 2017
Connecting Neuronal Cell Protective Pathways and Drug Combinations in a Huntington's Disease Model through the Application of Quantitative Systems PharmacologyFen Pei, Hongchun Li, Mark J Henderson, et al.
ESMO Open|February 20, 2021
Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trialJ A Ledermann, A C Embleton-Thirsk, T J Perren, et al.
Genes, Chromosomes & Cancer|February 1, 1997
Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlationsG Chenevix-Trench, J Kerr, T Hurst, et al.
Nature Medicine|February 22, 2023
Epidural stimulation of the cervical spinal cord for post-stroke upper-limb paresisMarc P Powell, Nikhil Verma, Erynn Sorensen, et al.
JAMA|June 21, 2001
Tularemia as a biological weapon: medical and public health managementD T Dennis, T V Inglesby, D A Henderson, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2005
The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infectionYusheng Xiong, Judyann Wiltsie, Andrea Woods, et al.
Global Change Biology|April 15, 2025
Multi-Species Telemetry Quantifies Current and Future Efficacy of a Remote Marine Protected AreaMorgan E Gilmour, Kydd Pollock, Josh Adams, et al.
Pageof 64